SHANGHAI, Feb. 28, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or "the Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it will be attending the Citibank 2011 Global Health Care Conference in New York from March 1 – 3, 2011.
William Dai, Chief Financial Officer of ShangPharma, will host a group presentation at 10:00 am (New York Time) on March 3, 2011.
The presentation materials will be available under the 'Webcast and Presentation' section of the Company's investor relations website: http://ir.shangpharma.com.
About ShangPharma Corp.
ShangPharma Corporation is a leading China-based contract research organization providing high-quality and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality, integrated services across the drug discovery and development process to help international and Chinese pharmaceutical and biotechnology companies discover and develop novel drug candidates efficiently. ShangPharma's services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. For more information, please visit www.shangpharma.com.
| ShangPharma Corporation |
| Lan Xie |
| VP of Finance and Operations |
| IR@shangpharma.com |
| or |
| Christensen |
| Kimberly Minarovich |
| +1-917-533-3268 (New York) |
| kminarovich@ChristensenIR.com |
| Tip Fleming |
| +852-9212-0684 (Hong Kong) |
| tfleming@ChristensenIR.com |
